Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Barinthus Biotherapeutics (BRNS) Receivables Refunds (2020 - 2023)

Historic Receivables Refunds for Barinthus Biotherapeutics (BRNS) over the last 4 years, with Q3 2023 value amounting to $1.7 million.

  • Barinthus Biotherapeutics' Receivables Refunds rose 1709000.0% to $1.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.7 million, marking a year-over-year increase of 1709000.0%. This contributed to the annual value of $705000.0 for FY2021, which is 13114.75% up from last year.
  • According to the latest figures from Q3 2023, Barinthus Biotherapeutics' Receivables Refunds is $1.7 million, which was up 1709000.0% from $10000.0 recorded in Q3 2022.
  • Barinthus Biotherapeutics' Receivables Refunds' 5-year high stood at $1.7 million during Q3 2023, with a 5-year trough of $10000.0 in Q3 2022.
  • Its 4-year average for Receivables Refunds is $641222.2, with a median of $542000.0 in 2021.
  • As far as peak fluctuations go, Barinthus Biotherapeutics' Receivables Refunds crashed by 9803.15% in 2022, and later soared by 1709000.0% in 2023.
  • Quarter analysis of 4 years shows Barinthus Biotherapeutics' Receivables Refunds stood at $305000.0 in 2020, then surged by 131.15% to $705000.0 in 2021, then crashed by 98.58% to $10000.0 in 2022, then soared by 17090.0% to $1.7 million in 2023.
  • Its Receivables Refunds was $1.7 million in Q3 2023, compared to $10000.0 in Q3 2022 and $1.0 million in Q2 2022.